102 related articles for article (PubMed ID: 27572636)
1. Possible tumor suppressive role of the miR-144/451 cluster in esophageal carcinoma as determined by principal component regression analysis.
Gao Z; Liu R; Liao J; Yang M; Pan E; Yin L; Pu Y
Mol Med Rep; 2016 Oct; 14(4):3805-13. PubMed ID: 27572636
[TBL] [Abstract][Full Text] [Related]
2. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma.
Yang M; Liu R; Sheng J; Liao J; Wang Y; Pan E; Guo W; Pu Y; Yin L
Oncol Rep; 2013 Jan; 29(1):169-76. PubMed ID: 23124769
[TBL] [Abstract][Full Text] [Related]
3. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
[TBL] [Abstract][Full Text] [Related]
4. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J
Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377
[TBL] [Abstract][Full Text] [Related]
5. Five miRNAs Considered as Molecular Targets for Predicting Esophageal Cancer.
Zhao JY; Wang F; Li Y; Zhang XB; Yang L; Wang W; Xu H; Liu DZ; Zhang LY
Med Sci Monit; 2015 Oct; 21():3222-30. PubMed ID: 26498375
[TBL] [Abstract][Full Text] [Related]
6. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
7. [Differential expression of hsa-miR-126 and hsa-miR-518b in esophageal squamous carcinoma].
Cai H; Wang JS; Zhang MX; Duan XY; Ma RQ
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):23-7. PubMed ID: 21269950
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
9. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
[TBL] [Abstract][Full Text] [Related]
10. [Expression profiles of microRNAs in radioresistant esophageal cell line].
Zheng ZF; Su HF; Zou Y; Peng Z; Wu SX
Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(9):639-42. PubMed ID: 21600139
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
13. Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma.
Akagi I; Miyashita M; Ishibashi O; Mishima T; Kikuchi K; Makino H; Nomura T; Hagiwara N; Uchida E; Takizawa T
Dis Esophagus; 2011 Sep; 24(7):523-30. PubMed ID: 21453382
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma.
Gong H; Song L; Lin C; Liu A; Lin X; Wu J; Li M; Li J
Clin Cancer Res; 2013 Mar; 19(5):1083-93. PubMed ID: 23319823
[TBL] [Abstract][Full Text] [Related]
16. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
[TBL] [Abstract][Full Text] [Related]
17. Alteration of miRNA expression correlates with lifestyle, social and environmental determinants in esophageal carcinoma.
Stánitz É; Juhász K; Gombos K; Gőcze K; Tóth C; Kiss I
Anticancer Res; 2015 Feb; 35(2):1091-7. PubMed ID: 25667498
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation on the gene expression signature in esophagus adenocarcinoma.
Xi T; Zhang G
Pathol Res Pract; 2017 Feb; 213(2):83-88. PubMed ID: 28049580
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.
Zhou S; Yang B; Zhao Y; Xu S; Zhang H; Li Z
J Surg Res; 2014 Dec; 192(2):515-20. PubMed ID: 25218280
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
Ladeiro Y; Couchy G; Balabaud C; Bioulac-Sage P; Pelletier L; Rebouissou S; Zucman-Rossi J
Hepatology; 2008 Jun; 47(6):1955-63. PubMed ID: 18433021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]